Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pariser

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
Journal of the American Academy of Dermatology|December 8, 1998
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trialD S Lange, H M Richards, J Guarnieri, et al.
Drug Safety|June 2, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLARRobert Bissonnette, Alice B Gottlieb, Richard G Langley, et al.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 TrialsM Alan Menter, Kim A Papp, Jennifer Cather, et al.
Cutis|February 18, 2004
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitisDonald V Belsito, Joseph F Fowler, James G Marks, et al.
Dermatologic Clinics|September 10, 2017
Integrating Skin Cancer-Related Technologies into Clinical PracticeRichard R Winkelmann, Aaron S Farberg, Alex M Glazer, et al.
International Journal of Dermatology|October 22, 2003
Ciclopirox gel in the treatment of patients with interdigital tinea pedisRaza Aly, George Fisher, Irving Katz, et al.
Dermatology and Therapy|March 28, 2025
CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability StudyDavid M Pariser, Mark G Lebwohl, Janusz Jaworski, et al.
American Journal of Clinical Dermatology|November 12, 2022
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b TrialLinda Stein Gold, Javier Alonso-Llamazares, Zoe D Draelos, et al.
Journal of Drugs in Dermatology : JDD|August 20, 2019
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 TrialsAndrew F. Alexis, Marta Rendon, Jonathan I. Silverberg, et al.
The British Journal of Dermatology|March 9, 2023
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trialZoe D Draelos, David N Adam, H Chih-Ho Hong, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Journal of the American Academy of Dermatology|December 8, 1998
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trialD S Lange, H M Richards, J Guarnieri, et al.
Drug Safety|June 2, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLARRobert Bissonnette, Alice B Gottlieb, Richard G Langley, et al.
Journal of Drugs in Dermatology : JDD|May 12, 2016
Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 TrialsM Alan Menter, Kim A Papp, Jennifer Cather, et al.
Cutis|February 18, 2004
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitisDonald V Belsito, Joseph F Fowler, James G Marks, et al.
Dermatologic Clinics|September 10, 2017
Integrating Skin Cancer-Related Technologies into Clinical PracticeRichard R Winkelmann, Aaron S Farberg, Alex M Glazer, et al.
International Journal of Dermatology|October 22, 2003
Ciclopirox gel in the treatment of patients with interdigital tinea pedisRaza Aly, George Fisher, Irving Katz, et al.
Dermatology and Therapy|March 28, 2025
CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability StudyDavid M Pariser, Mark G Lebwohl, Janusz Jaworski, et al.
American Journal of Clinical Dermatology|November 12, 2022
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b TrialLinda Stein Gold, Javier Alonso-Llamazares, Zoe D Draelos, et al.
Journal of Drugs in Dermatology : JDD|August 20, 2019
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 TrialsAndrew F. Alexis, Marta Rendon, Jonathan I. Silverberg, et al.
The British Journal of Dermatology|March 9, 2023
Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trialZoe D Draelos, David N Adam, H Chih-Ho Hong, et al.
Pageof 20